Catalyst Wire Dossier Catalyst Wire Dossier

NYLIA 1/35

NORETHINDRONE AND ETHINYL ESTRADIOL · Aurobindo Pharma Limited
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NYLIA 1/35, covering 2016-10-21 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: NYLIA 1/35 — Supplemental Application (Aurobindo Pharma Limited)

See pricing